SunSirs: Weak Demand Follow-up, China PA6 Market weakly Shocked

According to the data of SunSirs, the domestic PA6 market was adjusted in a narrow range in the first ten days of September, and each spot brand had a narrow range of rise and fall. As of September 11, the mainstream offer price of 2.75-2.85 from traders was about 10,950.00 RMB/ ton, a decrease of 0.45% compared with the average price at the beginning of the month.

PA6 upstream caprolactam market rose in early September. As of September 11, the average ex-factory price was about 9,650 RMB/ ton, up 1.40% from the average price at the beginning of the month, according to the data from SunSirs. At present, the operating rate of the enterprise is about 81%. The price of pure benzene in Shandong Province has risen slightly. In addition, due to the impact of the completion of maintenance of some downstream units in Shandong Province, the purchasing enthusiasm for pure benzene has increased. The price of styrene also rose, driving the continuous pursuit of pure benzene. The port inventory of pure benzene has increased recently, and the price rise is restricted by the inventory pressure. Downstream customers operate cautiously, and it is expected that China caprolactam market will be stable in the short term.

PA6 in early September market shock adjustment, upstream lactam prices have recovered, cost side support is acceptable. But on the whole, there is a lack of direction, guidance and good news. At present, the consumption level of downstream factories is not high, and the order follow-up is weak. There is resistance in the shipment of merchants, and there is profit making and single operation, and the trading atmosphere is relatively cold. Although the far end raw materials have rebounded recently, the overall trend is not good, the market confidence is insufficient, and the PA6 market atmosphere has not been improved.

Market Forecast

SunSirs analysts believe that: in early September, the domestic PA6 market trend is weak, and the spot price of each brand is up and down. The price of caprolactam in the upstream has recovered, and the cost side support of PA6 is acceptable. Downstream factory inventory is more sufficient, just take goods to operate, inquiry atmosphere is relatively light. Business mentality is not strong. It is expected that China PA6 market will continue its weak trend due to the weak demand in the near future.

If you have any questions, please feel free to contact SunSirs with support@sunsirs.com.